Vaccine Confidence Study Among Historically Marginalized Racial and Ethnic Groups

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBoston Medical Center

About this trial

Achieving optimal vaccination rates is vital for protecting the health and well-being of all individuals. This specific study focuses on the MMR and RSV vaccines in pregnancy and early childhood, which have been shown to reduce RSV and MMR-related illnesses, hospitalizations, and deaths. Efforts to improve vaccination rates have not been equally effective across the entire population; this has resulted in poorer outcomes from interventions for certain populations who are vaccine-hesitant.

This study seeks to understand how to best increase vaccine confidence in marginalized populations. To do this, the investigators will interview parents of children who receive care at Boston Medical Center (BMC), Community Health Workers and other Clinical providers at BMC, leading experts in the fields of vaccine confidence and implementation science, and key public health stakeholders/officials.

Eligibility criteria

Qualifiers

The birthing parent of any age of a child (aged 12-24 months) who receives primary care at Boston Medical Center

A birthing parent who is registered as a patient at Boston Medical Center

The birthing parent must have been pregnant between the months of October and February (RSV season)

The birthing parent must be comfortable completing an interview in English, Spanish, or Haitian Creole.

Disqualifiers

Clinical provider (including Community Health Workers, Physicians, Physician Assistants and Nurse Practitioners) at NON-BMC clinic/Community Health Center

Content experts - NON-Vaccine evidence based interventions (EBIs)

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

80 Participants
are grouped into 3 trial groups

Sponsors and collaborators

Boston Medical Center

Lead sponsor

Merck Sharp & Dohme LLC

Collaborator